Editas Medicine Q3'26 Earnings Preview
Editas Medicine is scheduled to report Q3'26 results on November 9. The report time is not specified.
Related stories
Loar shares jump 9.4% to an eight-week high
Loar Holdings rose 9.4% on Monday, reaching an eight-week high. The headline says the company may be included in the S&P SmallCap index.
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
Detroit Defense Awarded Four-Year Army IDIQ Contract Worth $49.9 Million
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
BMW Acquires 464,294 Shares Under Buyback Programme
BMW acquired 464,294 ordinary shares from 26 October through 1 November 2026 under its 2025/2027 buy-back programme.
M impact | EQUITY | Nov 02, 2026, 03:38 PM UTC
US Stocks Rise as Dow Gains 1.04%
The Dow rose 1.04%, the S&P 500 gained 0.58% and the Nasdaq advanced 0.72%.
M impact | EQUITY | Nov 02, 2026, 03:37 PM UTC
Wall Street Rises as Oil Falls Ahead of Midterm Elections
U.S. stocks rose as oil fell, with U.S. midterm elections and further earnings ahead.
M impact | EQUITY | Nov 02, 2026, 03:36 PM UTC
Bomb threat forces Wizz Air plane to make emergency landing
M impact | EQUITY | Nov 02, 2026, 03:36 PM UTC